The groundbreaking treatment of this peptide represents a major advance in the management of the condition. Different to existing medications, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide422509.losblogos.com/40697802/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment